Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
870 studies found for:    Alexander Disease
Show Display Options
Rank Status Study
21 Completed Allopurinol Maintenance Study for Bipolar Disorder
Conditions: Bipolar Disorder;   Mania;   Mixed Mania
Intervention: Drug: Allopurinol
22 Terminated Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography
Conditions: Coronary Atherosclerosis;   Coronary Artery Disease;   Radiocontrast-induced Thyroid Dysfunction;   Contrast-induced Nephropathy;   Cerebrovascular Disease;   Alzheimer's Disease
Interventions: Radiation: Coronary computed tomography angiography;   Radiation: Quantitative coronary angiography
23 Completed
Has Results
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
Conditions: Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder
Intervention: Drug: ziprasidone
24 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
25 Recruiting Catheter Placement for Hepatic Hydrothorax
Condition: Pleural Effusion
Intervention: Device: Indwelling tunneled pleural catheter (ITPC)
26 Terminated Ranibizumab and the Risk of Arterial Thromboembolic Events
Conditions: Age-related Macular Degeneration;   Coronary Artery Disease;   Cerebrovascular Disorders
Interventions: Drug: 0.5 mg of ranibizumab;   Procedure: 0.5 mg of ranibizumab + photodynamic therapy;   Other: Sham injection
27 Enrolling by invitation Genetic Evaluation of Families With Endocrine Cancers
Conditions: Pancreatic Cancer;   Thymic Cancer;   Parathyroid Disease;   MEN1 Syndrome
Intervention: Genetic: Blood draw
28 Enrolling by invitation Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
Condition: Erosive Esophagitis
Intervention: Radiation: Esophageal Barium Xray
29 Recruiting Home Therapy With VPRIV in Gaucher's Disease
Condition: Gaucher Disease
30 Not yet recruiting Meditation and Stretching for Post Treatment Lyme Disease Syndrome
Condition: Post Treatment Lyme Disease Syndrome
Intervention: Behavioral: Kundalini Yoga
31 Completed Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
Condition: Major Depressive Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate 20-50 mg
32 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
33 Completed Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
Conditions: OCD;   Anxiety Disorder
Intervention: Drug: Namenda (Memantine)
34 Completed Cognitive Behavioural Therapy of Early Dementia
Condition: Dementia
Interventions: Behavioral: Cognitive behavioral therapy for early Alzheimer's disease;   Other: Control
35 Recruiting Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery
Conditions: Coronary Artery Disease;   Heart Valve Diseases
Intervention: Device: CytoSorb device
36 Recruiting Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Condition: Peripheral Artery Disease
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
37 Completed Phase II Study With CC-10004 in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CC-10004;   Drug: Matching Placebo
38 Completed
Has Results
A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Biological: Motavizumab;   Biological: Palivizumab
39 Completed A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
40 Withdrawn Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Conditions: Chronic Kidney Disease;   Anemia
Intervention: Drug: Rilonacept

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years